Literature DB >> 31309917

The Comprehensive Assessment of Neurodegeneration and Dementia: Canadian Cohort Study.

Howard Chertkow1,2, Michael Borrie3,4, Victor Whitehead2, Sandra E Black5,6, Howard H Feldman7,8,9, Serge Gauthier10,11, David B Hogan12,9, Mario Masellis5,6, Katherine McGilton13,14, Kenneth Rockwood15, Mary C Tierney6,16, Melissa Andrew1,2,5,6,3,4,7,8,10,12,9,13,14,15,17,18,16,19,20,21,22,23,24,25,26,27,28,29,30,31,11, Ging-Yuek R Hsiung7,19, Richard Camicioli20,21, Eric E Smith9,22, Jennifer Fogarty4,23, Joseph Lindsay4, Sarah Best1,2,5,6,3,4,7,8,10,12,9,13,14,15,17,18,16,19,20,21,22,23,24,25,26,27,28,29,30,31,11, Alan Evans24, Samir Das25, Zia Mohaddes25, Randi Pilon2, Judes Poirier10, Natalie A Phillips26, Elizabeth MacNamara27, Roger A Dixon28, Simon Duchesne29,30, Ian MacKenzie31, R Jane Rylett14,15,17,18.   

Abstract

BACKGROUND: The Comprehensive Assessment of Neurodegeneration and Dementia (COMPASS-ND) cohort study of the Canadian Consortium on Neurodegeneration in Aging (CCNA) is a national initiative to catalyze research on dementia, set up to support the research agendas of CCNA teams. This cross-country longitudinal cohort of 2310 deeply phenotyped subjects with various forms of dementia and mild memory loss or concerns, along with cognitively intact elderly subjects, will test hypotheses generated by these teams.
METHODS: The COMPASS-ND protocol, initial grant proposal for funding, fifth semi-annual CCNA Progress Report submitted to the Canadian Institutes of Health Research December 2017, and other documents supplemented by modifications made and lessons learned after implementation were used by the authors to create the description of the study provided here.
RESULTS: The CCNA COMPASS-ND cohort includes participants from across Canada with various cognitive conditions associated with or at risk of neurodegenerative diseases. They will undergo a wide range of experimental, clinical, imaging, and genetic investigation to specifically address the causes, diagnosis, treatment, and prevention of these conditions in the aging population. Data derived from clinical and cognitive assessments, biospecimens, brain imaging, genetics, and brain donations will be used to test hypotheses generated by CCNA research teams and other Canadian researchers. The study is the most comprehensive and ambitious Canadian study of dementia. Initial data posting occurred in 2018, with the full cohort to be accrued by 2020.
CONCLUSION: Availability of data from the COMPASS-ND study will provide a major stimulus for dementia research in Canada in the coming years.

Entities:  

Keywords:  Alzheimers; Biomarkers; Cohort study; Dementia; Diagnosis; Frontotemporal dementia

Mesh:

Year:  2019        PMID: 31309917     DOI: 10.1017/cjn.2019.27

Source DB:  PubMed          Journal:  Can J Neurol Sci        ISSN: 0317-1671            Impact factor:   2.104


  11 in total

1.  Multi sequence average templates for aging and neurodegenerative disease populations.

Authors:  Mahsa Dadar; Richard Camicioli; Simon Duchesne
Journal:  Sci Data       Date:  2022-05-27       Impact factor: 8.501

2.  Cortical Thickness and Its Association with Clinical Cognitive and Neuroimaging Markers in Cerebral Amyloid Angiopathy.

Authors:  Arsenije Subotic; Cheryl R McCreary; Feryal Saad; Amanda Nguyen; Ana Alvarez-Veronesi; Angela M Zwiers; Anna Charlton; Andrew E Beaudin; Zahinoor Ismail; G Bruce Pike; Eric E Smith
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

3.  Diffusion tensor tractography of the fornix in cerebral amyloid angiopathy, mild cognitive impairment and Alzheimer's disease.

Authors:  Ibrahim Shaikh; Christian Beaulieu; Myrlene Gee; Cheryl R McCreary; Andrew E Beaudin; Diana Valdés-Cabrera; Eric E Smith; Richard Camicioli
Journal:  Neuroimage Clin       Date:  2022-04-04       Impact factor: 4.891

4.  Plasma Neurofilament Light: A Marker of Neurodegeneration in Mild Behavioral Impairment.

Authors:  James P Naude; Sascha Gill; Sophie Hu; Alexander McGirr; Nils D Forkert; Oury Monchi; Peter K Stys; Eric E Smith; Zahinoor Ismail
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

5.  Cerebral Amyloid Angiopathy Is Associated With Emotional Dysregulation, Impulse Dyscontrol, and Apathy.

Authors:  Eric E Smith; Stephanie Crites; Meng Wang; Anna Charlton; Angela Zwiers; Ramnik Sekhon; Tolulope Sajobi; Richard Camicioli; Cheryl R McCreary; Richard Frayne; Zahinoor Ismail
Journal:  J Am Heart Assoc       Date:  2021-11-10       Impact factor: 5.501

6.  Feasibility and preliminary efficacy of the LEAD trial: a cluster randomized controlled lifestyle intervention to improve hippocampal volume in older adults at-risk for dementia.

Authors:  N D Koblinsky; N D Anderson; F Ajwani; M D Parrott; D Dawson; S Marzolini; P Oh; B MacIntosh; L Middleton; G Ferland; C E Greenwood
Journal:  Pilot Feasibility Stud       Date:  2022-02-09

7.  The Relationship Between Hearing and Mild Behavioral Impairment and the Influence of Sex: A Study of Older Adults Without Dementia from the COMPASS-ND Study.

Authors:  Penny Gosselin; Dylan X Guan; Hung-Yu Chen; M Kathleen Pichora-Fuller; Natalie Phillips; Peter Faris; Eric E Smith; Zahinoor Ismail
Journal:  J Alzheimers Dis Rep       Date:  2022-02-18

8.  Cerebrovascular Reactivity Across the Entire Brain in Cerebral Amyloid Angiopathy.

Authors:  Andrew E Beaudin; Cheryl R McCreary; Erin L Mazerolle; Myrlene Gee; Breni Sharma; Arsenije Subotic; Angela M Zwiers; Emily Cox; Krista Nelles; Anna Charlton; Richard Frayne; Zahinoor Ismail; Christian Beaulieu; Glen C Jickling; Richard M Camicioli; G Bruce Pike; Eric E Smith
Journal:  Neurology       Date:  2022-02-24       Impact factor: 11.800

9.  Frailty Prevalence in the COMPASS-ND Study of Neurodegenerative Disorders.

Authors:  Jacqueline R Burt; Judith Godin; Josée Filion; Manuel Montero-Odasso; Kenneth Rockwood; Melissa K Andrew; Richard Camicioli
Journal:  Can Geriatr J       Date:  2019-12-30

10.  The Consortium for the early identification of Alzheimer's disease-Quebec (CIMA-Q).

Authors:  Sylvie Belleville; Andréa C LeBlanc; Marie-Jeanne Kergoat; Frédéric Calon; Pierrette Gaudreau; Sébastien S Hébert; Carol Hudon; Nicole Leclerc; Naguib Mechawar; Simon Duchesne; Serge Gauthier
Journal:  Alzheimers Dement (Amst)       Date:  2019-11-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.